Search clinical trials for: Glatiramer acetate
Total 3953 results
-
PfizerCompletedCrohn's DiseaseUnited States, Spain, Lebanon, Australia, Russian Federation, Korea, Republic of, Tunisia, Italy, Poland, Belgium, Austria, Germany, Saudi Arabia, Czechia, Hungary, Switzerland, Turkey, Slovakia, Ukraine, Georgia, Bosnia and Herzegovina and more
-
CinnagenCompletedRelapsing Multiple Sclerosis
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisRussian Federation
-
Teva Neuroscience, Inc.Completed
-
National Center for Research Resources (NCRR)University of MarylandCompleted
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of ExcellenceCompletedMultiple Sclerosis | Autoimmune DiseasesUnited States
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveNetherlands
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research InstituteActive, not recruitingRelapsing-remitting Multiple SclerosisSweden
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing-Remitting Multiple SclerosisUnited States, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Greece, Latvia, Macedonia, The Former Yugoslav Republic of, Mexico, Moldova, Republic of, Montenegro, Poland, Romania, Russian... and more
-
Hadassah Medical OrganizationWeizmann Institute of ScienceCompletedHeart Failure | Inflammatory Response | Acute Decompensated Heart Failure | Cytokine StormIsrael
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
Joachim ZdolsekRecruitingGynecologic Cancer | Colorectal Cancer | Colorectal Disorders | Urologic Cancer | Benign NeoplasmSweden
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
BiogenRecruitingMultiple SclerosisUnited States
-
University of Colorado, DenverRocky Mountain MS Research Group, LLCCompletedMultiple SclerosisUnited States
-
Eiger BioPharmaceuticalsApproved for marketing
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Italy, Spain, United Kingdom, Austria
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, Sweden, United States, France, Switzerland, Ireland, Canada, Australia, Brazil, Austria, Poland, Germany, Hungary, Netherlands, Russian Federation, Spain, Argentina, Slovenia, Greece, Finland, Denmark, Ukraine, Italy, L... and more
-
Wendell Yap, MDUniversity of Kansas Medical CenterNo longer availableProstate CancerUnited States
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisGermany, Spain, Italy, France, United Kingdom
-
University of MichiganNational Institutes of Health (NIH)CompletedHeart Failure | CardiomyopathiesUnited States
-
National Cancer Institute, EgyptCompleted
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
Uppsala UniversityTerminatedPostoperative Complications | Fluid Therapy | Fluid Overload | Pancreas Disease | Postoperative PeriodSweden
-
Jonsson Comprehensive Cancer CenterNo longer available
-
Vanderbilt University Medical CenterCompletedCritical Illness | Acidosis, MetabolicUnited States
-
Daniel VaenaCompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
IMPULS Endowment FundCompleted
-
Phoenix Molecular ImagingCompletedProstate CancerUnited States
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); Howard Hughes Medical InstituteRecruitingKidney Cancer | Renal Cell Carcinoma | Urothelial Carcinoma | Hereditary Leiomyomatosis and Renal Cell Cancer | Metastatic Urothelial Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | HLRCC | Clear Cell Carcinoma | Metastatic Kidney Cancer | Fumarate Hydratase Deficiency | Succinate...United States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Istituto Di Ricerche Farmacologiche Mario NegriRecruiting
-
Phoenix Molecular ImagingWithdrawn
-
Al-Azhar UniversityBenha UniversityCompleted
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
Genzyme, a Sanofi CompanyActive, not recruitingMultiple SclerosisPortugal, Turkey, Italy, Austria, Belgium, France, Netherlands, Poland, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsCompletedAsthmaSouth Africa, Belgium, Croatia, Turkey, Hungary, Colombia, Slovakia, Philippines, Russian Federation, Guatemala, Germany
-
University of Alabama at BirminghamNot yet recruiting
-
University of PennsylvaniaTerminatedMild Cognitive ImpairmentUnited States
-
Rigshospitalet, DenmarkUniversity of Iceland; OctapharmaCompleted
-
Repros Therapeutics Inc.CompletedUterine FibroidsUnited States
-
Repros Therapeutics Inc.CompletedImpaired Liver FunctionUnited States
-
Massachusetts General HospitalTerminated
-
Repros Therapeutics Inc.Withdrawn
-
Repros Therapeutics Inc.Completed
-
Repros Therapeutics Inc.CompletedABSORPTION | METABOLISM | EXCRETIONUnited States
-
Repros Therapeutics Inc.WithdrawnUterine FibroidsUnited States, Brazil